Nothing surprises me in this report. It is as expected i.e. cash is being used to build the generic pipeline. Good to see a little bit of growth on the Evamist and Lenzetto. The real value will come when they commercialise the generic pipeline and when sales start. At the moment, I guess they will be waiting for FDA approval on the 3 products submitted. Once we receive approval i'm sure we will see a licencing agreement soon after.
18m of cash left, looks like this will be enough for another year and a bit. Hopefully sales begins before then and we do not need a capital raise.
- Forums
- ASX - By Stock
- ACR
- Ann: Appendix 4E & Full Year Statutory Accounts
Ann: Appendix 4E & Full Year Statutory Accounts, page-3
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ACR (ASX) to my watchlist
|
|||||
Last
6.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $17.73M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 144142 | 5.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
6.1¢ | 100089 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 144142 | 0.059 |
3 | 126241 | 0.058 |
2 | 100908 | 0.055 |
1 | 88000 | 0.054 |
1 | 197000 | 0.051 |
Price($) | Vol. | No. |
---|---|---|
0.061 | 100089 | 2 |
0.062 | 200000 | 1 |
0.063 | 100000 | 1 |
0.064 | 12500 | 1 |
0.065 | 130000 | 1 |
Last trade - 10.33am 04/09/2024 (20 minute delay) ? |
Featured News
ACR (ASX) Chart |
Day chart unavailable